Feinstein Institute for Medical Research   Report issue

Contributed to NME Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Manhasset NY United States (1991)

Organization Overview

First Clinical Trial
2006
NCT00301418
First Marketed Drug
2005
fludeoxyglucose f-18
First NDA Approval
2019
fluorodopa (fluorodopa F18)
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Adrianna Vlachos | FEINSTEIN | Feinstein Institute | Feinstein Institute for Medical Research | Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases | Feinstein Institute for Medical Research North Shore-Long Island Jewish Health System | Feinstein Institute for Medical Research NS-LIJ Health System | Marc L Gordon, MD | THE FEINSTEIN INST | The Feinstein Institute for Medical Research | The Feinstein Institute for Medical Research NS-LIJ Health System